Author

Bai-ling Chen

wayne state university - Cited by 745 - molecular cell biology - organic chemistry

Biography

Bai-ling Chen Is currently working at the Department of Orthopaedics Bai-ling Chen, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China And has a major interest in the field of Orthopaedics
Title
Cited by
Year
Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin
B Chen, M Yu, Q Chang, Y Lu, C Thakur, D Ma, Z Yi, F ChenOncotarget 4 (9), 1427, 2013201
100
2013
85
2013
Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
K Wu, Q Chang, Y Lu, P Qiu, B Chen, C Thakur, J Sun, L Li, A Kowluru, ...Oncotarget 4 (12), 2430, 2013201
71
2013
JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure
J Liu, B Chen, Y Lu, Y Guan, F ChenToxicological sciences 129 (2), 363-371, 2012201
68
2012
Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation
J Sun, M Yu, Y Lu, C Thakur, B Chen, P Qiu, H Zhao, F ChenCancer letters 346 (2), 257-263, 2014201
56
2014
Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61 cancer stem cells
Q Chang, B Chen, C Thakur, Y Lu, F ChenOncotarget 5 (5), 1290, 2014201
52
2014
Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion
M Yu, J Sun, C Thakur, B Chen, Y Lu, H Zhao, F ChenPLoS One 9 (2), e87998, 2014201
45
2014
Reactive oxygen species contribute to arsenic-induced EZH2 phosphorylation in human bronchial epithelial cells and lung cancer cells
L Li, P Qiu, B Chen, Y Lu, K Wu, C Thakur, Q Chang, J Sun, F ChenToxicology and applied pharmacology 276 (3), 165-170, 2014201
43
2014
Increased expression of mdig predicts poorer survival of the breast cancer patients
C Thakur, Y Lu, J Sun, M Yu, B Chen, F ChenGene 535 (2), 218-224, 2014201
38
2014
Loss of mdig expression enhances DNA and histone methylation and metastasis of aggressive breast cancer
C Thakur, B Chen, L Li, Q Zhang, ZQ Yang, F ChenSignal transduction and targeted therapy 3 (1), 25, 2018201
34
2018
Synthesis and antileukemic activities of piperlongumine and HDAC inhibitor hybrids against acute myeloid leukemia cells
Y Liao, X Niu, B Chen, H Edwards, L Xu, C Xie, H Lin, L Polin, JW Taub, ...Journal of medicinal chemistry 59 (17), 7974-7990, 2016201
34
2016
Targeting prostate cancer cells with enzalutamide‐HDAC inhibitor hybrid drug 2‐75
WY Hu, L Xu, B Chen, S Ou, KM Muzzarelli, DP Hu, Y Li, Z Yang, ...The Prostate 79 (10), 1166-1179, 2019201
12
2019